Canberra: The Australian government has signed agreements on Thursday with pharmaceutical company Novavax and a consortium of companies, Pfizer and BioNTech, to supply 50 million doses of COVID-19 vaccines.
"Under the agreements, Novavax will supply 40 million vaccine doses and Pfizer/BioNTech will provide 10 million vaccine doses, should the vaccines be proven safe and effective," the statement on the Australian government website said.
Read:| US gives full approval for antiviral remdesivir drug
Australian Prime Minister Scott Morrison said the government's COVID-19 Vaccine and Treatment Strategy had now secured access to four types of vaccines and over 134 million doses.
"By securing multiple COVID-19 vaccines we are giving Australians the best shot at early access to a vaccine, should trials prove successful," the prime minister said.
Vaccines from Novavax and Pfizer-BioNTech are expected to be available in Australia starting in early 2021.
Read:| Johnson & Johnson and Aspen Pharmacare sign Covid -19 vaccine deal
On August 19, the Australian authorities signed an agreement with pharmaceutical company AstraZeneca for the supply of the COVID-19 vaccine, which the company is developing together with Oxford University. The authorities also signed an agreement with the University of Queensland, where the development of a vaccine is underway in conjunction with the Australian company, CSL Limited.
ANI
